Table 3.
Patients tested positive for the Alpha variant (n = 59) vs. patients tested negative for the Alpha variant (n = 6).
| Variable | Alpha Variant (n = 59) | No Alpha Variant (n = 6) | p-Value |
|---|---|---|---|
| Age (median) | 8.6 years | 14.0 years | p = 0.0953 |
| (min 0.0 years; max 17.8 years) | (min 7.1 years; max 16.3 years) | ||
| 0 ≤ 3 years | 20.3% (n = 12) | 0% (n = 0) | p = 0.5831 |
| 3 ≤ 6 years | 13.6% (n = 8) | 0% (n = 0) | p > 0.9999 |
| 6 ≤ 12 years | 37.3% (n = 22) | 44.4% (n = 2) | p > 0.9999 |
| 12 ≤ 18 years | 28.8% (n = 17) | 66.6% (n = 4) | p = 0.0800 |
| Gender (male) | 55.9% (n = 33) | 44.4% (n = 2) | p = 0.4025 |
| Suffering from a | 3.4% (n = 2) | 0% (n = 0) | p > 0.9999 |
| Chronic Disease | |||
| Contact to Somebody Recently Tested Positive for SARS-CoV-2 | 45.8% (n = 27) | 16.7% (n = 1) | p = 0.2245 |
| Symptomatic | 54.2% (n = 32) | 66.6% (n = 4) | p = 0.6841 |
| Fever | 25.7% (n = 15) | 0.0% (n = 0) | p = 0.3225 |
| Cough | 23.7% (n = 14) | 44.4% (n = 2) | p = 0.6306 |
| Rhinitis | 23.7% (n = 14) | 44.4% (n = 2) | p = 0.6306 |
| Headache | 11.9% (n = 7) | 2.9% (n = 1) | p = 0.5607 |
| Dyspnea | 8.5% (n = 5) | 0.0% (n = 0) | p > 0.9999 |
| Sore Throat | 6.8% (n = 4) | 44.4% (n = 2) | p = 0.0908 |
| Gastrointestinal Symptoms | 6.8% (n = 4) | 0.0% (n = 0) | p > 0.9999 |
| Myalgia | 5.1% (n = 3) | 0.0% (n = 0) | p > 0.9999 |
| Dysgeusia and Dysosmia | 1.7% (n = 1) | 16.7% (n = 1) | p > 0.9999 |
| Admission to Hospital | 20.3% (n = 12) | 0.0% (n = 0) | p = 0.5831 |
| for COVID-19 | 15.3% (n = 9) | 0.0% (n = 0) | p = 0.5838 |
| Ct Value (median) | 24.0 (min 17.0; max 32.7) | 25.0 (min 19.0; max 32.0) | p = 0.3886 |